Fulgent Genetics (FLGT) Ratios
Fulgent Genetics Ratios
MX:FLGT's free cash flow for Q2 2026 was $-27.62M. For the 2026 fiscal year, MX:FLGT's free cash flow was decreased by $-3.86M and operating cash flow was $-23.76M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.48 | 4.85 | 6.96 | 7.13 | 5.81 |
| Quick Ratio | 6.35 | 4.74 | 6.96 | 7.08 | 5.70 |
| Cash Ratio | 0.59 | 0.76 | 1.33 | 0.90 | 1.57 |
| Solvency Ratio | -0.34 | -0.20 | -1.39 | 1.52 | 4.59 |
| Operating Cash Flow Ratio | -1.20 | 0.29 | 0.37 | 2.88 | 5.11 |
| Short-Term Operating Cash Flow Coverage | -213.53 | 51.12 | 22.83 | 12.28 | 25.30 |
| Net Current Asset Value | $ 443.68M | $ 262.77M | $ 405.80M | $ 511.69M | $ 499.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.09 | 1.08 | 1.09 | 1.09 | 1.10 |
| Debt Service Coverage Ratio | -67.94 | -32.17 | -88.93 | 8.11 | 24.06 |
| Interest Coverage Ratio | -1214.61 | -434.81 | -400.67 | 176.24 | 0.00 |
| Debt to Market Cap | 0.00 | 0.01 | 0.00 | 0.03 | 0.01 |
| Interest Debt Per Share | 0.25 | 0.29 | 0.53 | 1.33 | 0.72 |
| Net Debt to EBITDA | 0.93 | 1.74 | 0.56 | -0.19 | -0.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.56% | 37.82% | 36.12% | 59.28% | 78.29% |
| EBIT Margin | -21.68% | -18.27% | -60.02% | 29.89% | 68.10% |
| EBITDA Margin | -14.20% | -9.47% | -50.98% | 35.17% | 69.21% |
| Operating Profit Margin | -28.23% | -26.08% | -67.61% | 28.84% | 68.10% |
| Pretax Profit Margin | -21.70% | -18.33% | -60.19% | 29.73% | 68.61% |
| Net Profit Margin | -18.75% | -15.07% | -58.03% | 23.17% | 51.12% |
| Continuous Operations Profit Margin | -19.10% | -15.46% | -60.59% | 22.93% | 51.00% |
| Net Income Per EBT | 86.42% | 82.20% | 96.40% | 77.93% | 74.50% |
| EBT Per EBIT | 76.87% | 70.29% | 89.03% | 103.08% | 100.75% |
| Return on Assets (ROA) | -4.99% | -3.50% | -13.59% | 10.35% | 39.68% |
| Return on Equity (ROE) | -5.44% | -3.77% | -14.77% | 11.32% | 43.79% |
| Return on Capital Employed (ROCE) | -8.07% | -6.44% | -16.82% | 13.75% | 57.61% |
| Return on Invested Capital (ROIC) | -7.09% | -5.43% | -16.75% | 10.39% | 42.06% |
| Return on Tangible Assets | -5.73% | -4.02% | -15.68% | 13.13% | 42.57% |
| Earnings Yield | -7.48% | -7.65% | -19.49% | 16.00% | 17.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.52 | 3.68 | 5.03 | 8.24 | 6.93 |
| Payables Turnover | 10.28 | 9.60 | 12.03 | 10.92 | 10.52 |
| Inventory Turnover | 18.09 | 21.02 | 0.00 | 58.89 | 17.66 |
| Fixed Asset Turnover | 2.87 | 2.69 | 3.02 | 7.61 | 15.94 |
| Asset Turnover | 0.27 | 0.23 | 0.23 | 0.45 | 0.78 |
| Working Capital Turnover Ratio | 0.86 | 0.79 | 0.59 | 1.18 | 2.21 |
| Cash Conversion Cycle | 88.31 | 78.52 | 42.15 | 17.05 | 38.66 |
| Days of Sales Outstanding | 103.63 | 99.18 | 72.50 | 44.29 | 52.69 |
| Days of Inventory Outstanding | 20.18 | 17.36 | 0.00 | 6.20 | 20.67 |
| Days of Payables Outstanding | 35.50 | 38.03 | 30.34 | 33.44 | 34.71 |
| Operating Cycle | 123.81 | 116.55 | 72.50 | 50.49 | 73.36 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.30 | 0.70 | 0.91 | 8.42 | 18.31 |
| Free Cash Flow Per Share | -4.04 | -0.64 | 0.16 | 7.80 | 17.50 |
| Dividend Paid and CapEx Coverage Ratio | -4.50 | 0.52 | 1.22 | 13.50 | 22.59 |
| Capital Expenditure Coverage Ratio | -4.50 | 0.52 | 1.22 | 13.50 | 22.59 |
| Operating Cash Flow Coverage Ratio | -13.24 | 2.49 | 1.77 | 6.51 | 25.30 |
| Operating Cash Flow to Sales Ratio | -0.31 | 0.07 | 0.09 | 0.41 | 0.54 |
| Free Cash Flow Yield | -15.36% | -3.45% | 0.56% | 26.19% | 17.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -13.34 | -13.10 | -5.13 | 6.25 | 5.83 |
| Price-to-Sales (P/S) Ratio | 2.51 | 1.97 | 2.98 | 1.45 | 2.98 |
| Price-to-Book (P/B) Ratio | 0.73 | 0.49 | 0.76 | 0.71 | 2.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.51 | -29.00 | 179.54 | 3.82 | 5.75 |
| Price-to-Operating Cash Flow Ratio | -7.95 | 26.52 | 31.89 | 3.54 | 5.49 |
| Price-to-Earnings Growth (PEG) Ratio | -0.34 | 0.17 | 0.02 | -0.09 | 0.07 |
| Enterprise Value Multiple | -16.71 | -19.05 | -5.28 | 3.93 | 4.10 |
| Enterprise Value | 766.00M | 511.76M | 778.83M | 855.72M | 2.81B |
| EV to EBITDA | -16.71 | -19.05 | -5.28 | 3.93 | 4.10 |
| EV to Sales | 2.37 | 1.81 | 2.69 | 1.38 | 2.84 |
| EV to Free Cash Flow | -6.17 | -26.58 | 162.39 | 3.65 | 5.47 |
| EV to Operating Cash Flow | -7.54 | 24.30 | 28.84 | 3.38 | 5.23 |
| Tangible Book Value Per Share | 30.81 | 32.15 | 32.51 | 32.44 | 36.69 |
| Shareholders’ Equity Per Share | 36.13 | 37.48 | 38.14 | 42.09 | 39.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.12 | 0.16 | -0.01 | 0.23 | 0.26 |
| Revenue Per Share | 10.48 | 9.38 | 9.71 | 20.57 | 33.75 |
| Net Income Per Share | -1.97 | -1.41 | -5.63 | 4.76 | 17.25 |
| Tax Burden | 0.86 | 0.82 | 0.96 | 0.78 | 0.74 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.01 |
| Research & Development to Revenue | 0.17 | 0.17 | 0.14 | 0.05 | 0.02 |
| SG&A to Revenue | 0.50 | 0.44 | 0.31 | 0.18 | 0.05 |
| Stock-Based Compensation to Revenue | 0.12 | 0.16 | 0.15 | 0.05 | 0.02 |
| Income Quality | 1.65 | -0.48 | -0.15 | 1.79 | 1.06 |
Currency in USD